• Etiologie

  • Facteurs exogènes : Environnement

Increased Lung and Bladder Cancer Incidence In Adults After In Utero and Early-Life Arsenic Exposure

Menée au Chili auprès de 381 cas et 508 témoins, cette étude évalue l'association entre une exposition à l'arsenic, in utero et au début de la vie, et le risque de cancer du poumon et de la vessie à l'âge adulte

Background: From 1958-70, >100,000 people in northern Chile were exposed to a well-documented, distinct period of high drinking water arsenic concentrations. We previously reported ecological evidence suggesting that early-life exposure in this population resulted in increased mortality in adults from several outcomes including lung and bladder cancer. Methods: We have now completed the first study ever assessing incident cancer cases after early-life arsenic exposure, and the first study on this topic with individual participant exposure and confounding factor data. Subjects included 221 lung and 160 bladder cancer cases diagnosed in northern Chile from 2007-2010, and 508 age and gender-matched controls. Results: Odds ratios (ORs) adjusted for age, sex, and smoking in those only exposed in early-life to arsenic water concentrations of ≤110, 110-800, and >800 µg/L were 1.00, 1.88 (95% confidence interval (CI), 0.96-3.71), and 5.24 (3.05-9.00) (p-trend<0.001) for lung cancer, and 1.00, 2.94 (1.29-6.70), and 8.11 (4.31-15.25) (p-trend<0.001) for bladder cancer. ORs were lower in those not exposed until adulthood. The highest category (>800 µg/L) involved exposures which started 49-52 years before, and ended 37-40 years before the cancer cases were diagnosed. Conclusions: Lung and bladder cancer incidence in adults was markedly increased following exposure to arsenic in early-life, even up to 40 years after high exposures ceased. Findings like these have not been identified before for any environmental exposure, and suggest that humans are extraordinarily susceptible to early-life arsenic exposure. Impact: Policies aimed at reducing early-life exposure may help reduce the long-term risks of arsenic-related disease.

Cancer Epidemiology Biomarkers & Prevention 2014

Voir le bulletin